FSH Fast Test Kit - India CDSCO Medical Device Registration

FSH Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_57ba7b22334aad2c16f90dfc96fe49a6_f7f632e268ff80976ae0f82da531fc5b. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

FSH Fast Test Kit

UID: IMP/IVD/2022/000153_57ba7b22334aad2c16f90dfc96fe49a6_f7f632e268ff80976ae0f82da531fc5b

Brand Name

Immunofluorescence Assay

License Holder

Cipla Limited

Device Class

Class B

Approving Authority

CDSCO

Product Information

FSH Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of FSH in human serum and plasma. FSH testing is used for women suspected of having polycystic ovary syndrome, and in individuals undergoing evaluation for infertility, also used for evaluation of individuals with suspected pituitary disorders or diseases of the ovaries